Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 65, 2010 - Issue 6
27
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

PREVALENCE OF CHRONIC RENAL FAILURE STAGE 3 OR MORE IN HIV-INFECTED PATIENTS IN ANTWERP: AN OBSERVATIONAL STUDY

, , , , &
Pages 392-398 | Published online: 30 May 2014

REFERENCES

  • Van Sighem A, Danner S, Ghani AC, Gras L, Anderson RM, de Wolf F; ATHENA National Observational Cohort Study. Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individuals.' Acquir Immune Defic Syndr 2005; 40: 212–8.
  • BarriosV, Escobar C, Echarri R. Chronic Kidney Disease: the forgotten cardio-vascular risk factor. Intl Clin Pract 2009; 63: 964–965.
  • El Sadr WM, Lundgren JD, Neaton JD et al. CD4 count-guided interruption of antiretoviral treatment. N Engel Med 2007; 356: 1723–1735.
  • Ener RA, Palermo J, O'Murchu B, Burke JA, Wolf NM, Van Decker WA. HIV disease in thrombocardiology. 'Invasive Cardiol 2007; 5:235–9.
  • Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. Highly Active Antiretrovirial Therapy and the epidemic of HIV+ End-stage Renal disease. J Am Soc Nephrol 2005; 16:2412–2420.
  • Wyatt CM, Arons RR, Klotman PE, Klotman ME. Acute renal failure in hospi-talized patients with HIV: risk factors and impact on in-hospital mortality. AIDS 2006; 20: 561–565.
  • Tourret J, Tostivint I, Tézenas Du Montcel S et al. Antiretroviral drug dosis er-rors in HIV-infected patients undergoing hemodialysis. Clin Infect Dis 2007; 45: 779–84.
  • Szczech LA, Hoover DR, Feldman JG et al.Association between renal disease and outcomes among HIV-infected women receiving or not receiving anti-retroviral therapy. Clin Infect Dis 2004; 39:1199–206.
  • Wyatt CM, Winston JA, Malvestutto CD et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS 2007; 21: 2101–3.
  • Selik RM, Byers RH Jr, Dworkin MS. Trends in diseases reported on US death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 2002; 29: 378–387.
  • Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney dis-ease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races.' Infect Dis 2008; 197: 1490–2.
  • Choi Al, Rodriguez RA, Bacchetti Petal. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis 2007; 45: 1633–9.
  • Zimmermann AE, Pizzoferrato T, Bedford J, Morris A, Hoffman R, Braden G. Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. Gin Infect Dis 2005; 42: 283–90.
  • Quimby D, Brito MO. Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature. AIDS 2005; 15: 357–64.
  • Gallant JE, Moore RD. Renal function with use of a tenofovir-containing intitial antiretroviral regimen. AIDS 2009; 23:1971–5.
  • Kearny BP, Mathias A, Mittan A, Sayre J, Ebrahimi R, Cheng AK. Pharmacoki-netics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir. JAcquir Immune Defic Syndr 2006; 43: 278–083.
  • Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci 2008; 335: 89–94.
  • Mocroft A, Kirk O, Gatell J, et al. Chronic renal failure among HIV-1-infected patients. AIDS 2007; 21: 1119–27.
  • Morlat PJM, Deti E, Lawson-Ayayi S et al. Prevalence and factors associated with renal failure in HIV infected patients, ANRS Aquitaine Cohort, France. Sydney 2007- International AIDS Society.
  • Cheung CY, Wong KM, Lee MP et al. Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant 2007; 22: 3186–90.
  • Kalayjian RC, Franceschini N, Gupta SK et al. Suppression of HIV-1 replica-tion by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS 2008; 22:481–7.
  • K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. American Journal of Kidney Diseases 2002; 39 (2, Sup).
  • Van Biesen W, de Bacquer D, Verbeke F, Delanghe E, Lameire N, Vanholder R. The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur HeartJ 2007; 28: 478–483.
  • Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038–2047.
  • Choi Al, Shlipak MG, Hunt PW, Martin JN, Deeks SG. HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy. AIDS 2009; 23: 2143–9.
  • Wyatt CM, Klotman PE. HIV-associated nephropathy in the era of antiretro-viral therapy. AmJ Med 2007; 6: 488–492.
  • Casau NC. Perspective on HIV infection and aging: emerging research on the horizon. Clin Infect Dis 2005; 41:855–63.
  • Sasse A, Defraye A. HIV/AIDS in BelgiC. Semestrieel rapport nr 68. Toestand op 31 december 2008 Epidemiologie Afdeling, mei 2009, Brussel (Belgid) Wetenschappelijk InstituutVolksgezondheid, IPH/EPI REPORTS N° 2009/28.
  • Krawczyk CS, Holmberg SD, Moorman AC, Gardner LI, McGwin G jr, HIV Outpatient Study Group. Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS 2004; 18:2171–2178.
  • Wild SH, Fischbacher C, Brock A, Griffiths C, Bhopal R. Mortality from all causes and circulatory disease by country of birth in England and Wales 2001-2003. J Public Health (Oxf) 2007; 29: 191–8.
  • Harding S, Teyhan A, Rosato M, Santana P. All cause and cardiovascular mor-tality in African migrants living in Portugal: evidence of large social inequali-ties. Eur J Cardiovasc Prey Rehabil 2008; 15: 670–6.
  • Dominguez LJ, Galioto A, Pineo A. Blood pressure and cardiovascular risk profiles of Africans who migrate to a Western country. Ethn Dis 2008;18: 512–8.
  • BeLue R, Okoror TA, lwelunmor J. An overview of cardiovascular risk factor burden in sub Saharan African countries: a socio-cultural perspective. Global Health 2009; 5: 10.
  • Barrios A, Garcia-Benayas T, Gonzalez-Lahoz J, Soriano V. Tenofovir-related nephrotoxicity in HIV-infected patients. AIDS 2004; 18:960–963.
  • Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048–1056.
  • De Jong P, van der Velde M, Gansevoort R, Zoccali C. Screening for Chronic Kidney Disease: Where Does Europe Go? din J Am Soc Nephrol 2008; 3: 616–623.
  • Gupta SK, Eustace JA, Winston JA et al. Guidelines for the management of chronic kidney disease in hiv-infected patients: recommendations of the HIV medicine association of the infectious diseases society of America. Clin Infect Dis 2005; 40: 1559–1585.
  • Clumeck N, Pozniak A, Raffi F; EACS Executive Committee. European AIDS Clinical Society (EACS).Guidelines for the clinical management and treat-ment of HIV-infected adults. HIV Med 2008; 9:65–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.